skip to Global Navigation Bar skip to main content


homeHome > About Us > Press Release > News

News

News Content
Daewoong Pharmaceutical presented its vision and R&D capacity at the ‘5th China Healthcare Summit’
Date 2018-11-16 Hit 1322
list
News List
Prev Daewoong Pharmaceutical Quality Task Team receives a gold medal for the first time in pharmaceutical industry in ICQCC 2018
Next Daewoong Pharmaceutical’s ‘NABOTA’ becomes the first Korea-made Botulinum Toxin to obtain US FDA approval